MADIT II trial: A 2002 breakthrough in primary prevention of mortality with implantable cardioverter-defibrillator

被引：0
作者：
Zareba, Wojciech [1 ]
机构：
[1] Univ Rochester, Clin Cardiovasc Res Ctr, Med Ctr, Cardiol Div, 601 Elmwood Ave,Box 653, Rochester, NY 14642 USA
来源：
HEART RHYTHM | 2025年 / 22卷 / 04期
关键词：
RISK;
D O I：
10.1016/j.hrthm.2025.02.019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：882 / 883
页数：2
相关论文
共 50 条
  • [1] Death with an implantable cardioverter-defibrillator: a MADIT-II substudy
    Chernomordik, Fernando
    Jons, Christian
    Klein, Helmut U.
    Kutyifa, Valentina
    Nof, Eyal
    Zareba, Wojciech
    Daubert, James P.
    Greenberg, Henry
    Glikson, Michael
    Goldenberg, Ilan
    Beinart, Roy
    EUROPACE, 2019, 21 (12): : 1843 - 1850
  • [2] Clinical Outcomes and Mortality in Patients with Implantable Cardioverter-Defibrillator for Primary Prevention
    Baskurt, Ahmet Anil
    Guneri, Sema
    Yilancioglu, Resit Yigit
    Turan, Oguzhan Ekrem
    Ozcan, Emin Evren
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2025, 122 (02)
  • [3] Gender Differences in Implantable Cardioverter-Defibrillator Utilization for Primary Prevention of Sudden Cardiac Death
    Dahiya, Garima
    Chen, Jane
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2021, 23 (12)
  • [4] Incidence of Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Heart Failure Treated With Combined Cardiac Resynchronization Plus Implantable Cardioverter-Defibrillator Therapy Versus Implantable Cardioverter-Defibrillator Therapy
    Desai, Harit
    Aronow, Wilbert S.
    Ahn, Chul
    Tsai, Fausan S.
    Lai, Hoang M.
    Gandhi, Kaushang
    Amin, Harshad
    Frishman, William H.
    Kalapatapu, Kumar
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (01) : 37 - 40
  • [5] The subcutaneous implantable cardioverter-defibrillator in review
    Kamp, Nicholas J.
    Al-Khatib, Sana M.
    AMERICAN HEART JOURNAL, 2019, 217 : 131 - 139
  • [6] Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population
    Levy, Wayne C.
    Lee, Kerry L.
    Hellkamp, Anne S.
    Poole, Jeanne E.
    Mozaffarian, Dariush
    Linker, David T.
    Maggioni, Aldo P.
    Anand, Inder
    Poole-Wilson, Philip A.
    Fishbein, Daniel P.
    Johnson, George
    Anderson, Jill
    Mark, Daniel B.
    Bardy, Gust H.
    CIRCULATION, 2009, 120 (10) : 835 - 842
  • [7] Implantable cardioverter-defibrillator therapy in primary versus secondary prevention: Reliable prediction of appropriate therapies and mortality is still an unmet need
    Tsuji, Yukiomi
    Dobrev, Dobromir
    IJC HEART & VASCULATURE, 2021, 32
  • [8] Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death
    DeMazumder, Deeptankar
    Limpitikul, Worawan B.
    Dorante, Miguel
    Dey, Swati
    Mukhopadhyay, Bhasha
    Zhang, Yiyi
    Moorman, J. Randall
    Cheng, Alan
    Berger, Ronald D.
    Guallar, Eliseo
    Jones, Steven R.
    Tomaselli, Gordon F.
    EUROPACE, 2016, 18 (12): : 1818 - 1828
  • [9] Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort
    Ruwald, Martin H.
    Ruwald, Anne-Christine
    Johansen, Jens Brock
    Gislason, Gunnar
    Nielsen, Jens Cosedis
    Philbert, Berit
    Riahi, Sam
    Vinther, Michael
    Lindhardt, Tommi B.
    EUROPACE, 2019, 21 (08): : 1211 - 1219
  • [10] Statins Reduce Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Failure and Combined Heart Cardiac Resynchronization and Implantable Cardioverter-Defibrillator Therapy
    Desai, Harit
    Aronow, Wilbert S.
    Tsai, Fausan S.
    Ahn, Chu
    Lai, Hoang M.
    Amin, Harshad
    Gandhi, Kaushang
    Frishman, William H.
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 14 (03) : 176 - 179
12345